LARIO THERAPEUTICS LIMITED

Active Edinburgh

Research and experimental development on biotechnology

1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
L

LARIO THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 26 Nov 2021 Active Edinburgh, United Kingdom 1 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 29 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 16 Dec 2025 Next due 9 Dec 2026 7 months remaining
Net assets £-5M £2M 2024 year on year
Total assets £3M £209K 2024 year on year
Total Liabilities £7M £2M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

137a George Street Edinburgh EH2 4JY United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for LARIO THERAPEUTICS LIMITED (SC716204), an active life sciences and medical technology company based in Edinburgh, United Kingdom. Incorporated 26 Nov 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£1.36M

Increased by £999.24k (+273%)

Net Assets

-£4.79M

Decreased by £1.88M (-65%)

Total Liabilities

£7.38M

Increased by £2.09M (+40%)

Turnover

N/A

Employees

1

Debt Ratio

284%

Increased by 62 (+28%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 2Nov 2021Seed
Investor 3Nov 2021Seed
Investor 4Nov 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 657,961 Shares £14.20m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Jun 202538,693£38.693£0.001
14 Mar 202595,786£2.61m£27.2
14 Mar 202595,786£2.61m£27.2
14 Mar 2025111,822£3.74m£33.48
14 Mar 2025111,822£3.74m£33.48

Officers

Officers

2 active 1 resigned
Status
Chiara Rossana Maria LiberatiDirectorItalianItaly551 Jun 2023Active
Henning Klaus-willi Christian SteinhagenDirectorGermanGermany5626 Nov 2021Active

Shareholders

Shareholders (13)

Epidarex Capital Iii Uk Lp
40.4%
186,534
Epidarex Capital Iii Uk Lp
21.7%
100,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 28 Mar 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Henning Klaus-willi Christian Steinhagen

Ceased 25 Mar 2022

Ceased

Group Structure

Group Structure

LARIO THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Dec 2025Confirmation StatementConfirmation statement made on 25 Nov 2025 with updates
29 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
14 Aug 2025CapitalAllotment of shares (GBP 461.353) on 16 Jun 2025
2 Jul 2025IncorporationMemorandum Articles
2 Jul 2025ResolutionResolutions
16 Dec 2025 Confirmation Statement

Confirmation statement made on 25 Nov 2025 with updates

29 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

14 Aug 2025 Capital

Allotment of shares (GBP 461.353) on 16 Jun 2025

2 Jul 2025 Incorporation

Memorandum Articles

2 Jul 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 25 Nov 2025 with updates

4 months ago on 16 Dec 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 29 Sept 2025

Allotment of shares (GBP 461.353) on 16 Jun 2025

8 months ago on 14 Aug 2025

Memorandum Articles

10 months ago on 2 Jul 2025

Resolutions

10 months ago on 2 Jul 2025